302 related articles for article (PubMed ID: 19954274)
1. Treatment strategies for juvenile idiopathic arthritis.
Klein A; Horneff G
Expert Opin Pharmacother; 2009 Dec; 10(18):3049-60. PubMed ID: 19954274
[TBL] [Abstract][Full Text] [Related]
2. Update on biologicals for treatment of juvenile idiopathic arthritis.
Horneff G
Expert Opin Biol Ther; 2013 Mar; 13(3):361-76. PubMed ID: 23289865
[TBL] [Abstract][Full Text] [Related]
3. Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis.
Correll CK; Binstadt BA
Pediatr Res; 2014 Jan; 75(1-2):176-83. PubMed ID: 24213625
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids in juvenile idiopathic arthritis.
Malattia C; Martini A
Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis.
Lin YT; Wang CT; Gershwin ME; Chiang BL
Autoimmun Rev; 2011 Jun; 10(8):482-9. PubMed ID: 21320644
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis - what the clinician needs to know.
Kahn PJ
Bull Hosp Jt Dis (2013); 2013; 71(3):194-9. PubMed ID: 24151944
[TBL] [Abstract][Full Text] [Related]
7. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
[TBL] [Abstract][Full Text] [Related]
8. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
Saxena N; Aggarwal A; Misra R
J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
[TBL] [Abstract][Full Text] [Related]
9. Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives.
Wahezi DM; Ilowite NT
Expert Opin Pharmacother; 2013 Jun; 14(8):975-89. PubMed ID: 23528005
[TBL] [Abstract][Full Text] [Related]
10. [Current therapy of polyarticular forms of juvenile idiopathic arthritis].
Hospach A; Rühlmann JM; Weller-Heinemann F
Z Rheumatol; 2016 Apr; 75(3):284-91. PubMed ID: 27001055
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
Yokota S; Kikuchi M; Nozawa T; Kanetaka T; Sato T; Yamazaki K; Sakurai N; Hara R; Mori M
Mod Rheumatol; 2015 Jan; 25(1):1-10. PubMed ID: 24842480
[TBL] [Abstract][Full Text] [Related]
12. Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.
Berard RA; Laxer RM
Expert Opin Biol Ther; 2013 Nov; 13(11):1623-30. PubMed ID: 24070010
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab for the treatment of systemic juvenile idiopathic arthritis.
Herlin T
Expert Rev Clin Immunol; 2012 Aug; 8(6):517-25. PubMed ID: 22992145
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.
Zhou J; Tang X; Ding Y; An Y; Zhao X
Pediatr Allergy Immunol; 2013 Nov; 24(7):691-6. PubMed ID: 24112428
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs to treat juvenile idiopathic arthritis.
Ruperto N; Martini A
Expert Opin Emerg Drugs; 2011 Sep; 16(3):493-505. PubMed ID: 21529300
[TBL] [Abstract][Full Text] [Related]
16. High doses of infliximab in the management of juvenile idiopathic arthritis.
Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
[TBL] [Abstract][Full Text] [Related]
17. Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis.
De Sanctis S; Marcovecchio ML; Gaspari S; Del Torto M; Mohn A; Chiarelli F; Breda L
J Rheumatol; 2013 Jun; 40(6):943-8. PubMed ID: 23547210
[TBL] [Abstract][Full Text] [Related]
18. Physical activity in patients with oligo- and polyarticular juvenile idiopathic arthritis diagnosed in the era of biologics: a controlled cross-sectional study.
Risum K; Hansen BH; Selvaag AM; Molberg Ø; Dagfinrud H; Sanner H
Pediatr Rheumatol Online J; 2018 Oct; 16(1):64. PubMed ID: 30333025
[TBL] [Abstract][Full Text] [Related]
19. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
20. Juvenile idiopathic arthritis.
Espinosa M; Gottlieb BS
Pediatr Rev; 2012 Jul; 33(7):303-13. PubMed ID: 22753788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
